Dysfunctional endothelial progenitor cells in metabolic syndrome

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Devaraj, Sridevi ^a,b   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GELATINASE B; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INCRETIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; VASCULOTROPIN RECEPTOR 2;

CARDIOVASCULAR DISEASE; CELL ADHESION; CELL COUNT; CELL FUNCTION; CELL MIGRATION; DIABETES MELLITUS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL PROGENITOR CELL; HUMAN; METABOLIC SYNDROME X; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; ATHEROSCLEROSIS; CHEMISTRY; ENDOTHELIUM CELL; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; STEM CELL;

ANTIGENS, CD34; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; CELL COUNT; ENDOTHELIAL CELLS; HUMANS; METABOLIC SYNDROME X; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 81555201107     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/585018     Document Type: Review

References (34)

1. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) Journal of the American Medical Association 2001 285 19 2486 2497 (Pubitemid 32433843)
2. Alberti K. G. M. M., Eckel R. H., Grundy S. M., Zimmet P. Z., Cleeman J. I., Donato K. A., Fruchart J. C., James W. P. T., Loria C. M., Smith S. C., Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American heart association; World heart federation; International atherosclerosis society; and international association for the study of obesity Circulation 2009 120 16 1640 1645
3. Lakka H. M., Laaksonen D. E., Lakka T. A., Niskanen L. K., Kumpusalo E., Tuomilehto J., Salonen J. T., The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men Journal of the American Medical Association 2002 288 21 2709 2716 (Pubitemid 35403784)
4. Esposito K., Ciotola M., Carleo D., Schisano B., Saccomanno F., Sasso F. C., Cozzolino D., Assaloni R., Merante D., Ceriello A., Giugliano D., Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome Diabetes Care 2006 29 5 1071 1076 (Pubitemid 44115246)
5. Hamburg N. M., Larson M. G., Vita J. A., Vasan R. S., Keyes M. J., Widlansky M. E., Fox C. S., Mitchell G. F., Levy D., Meigs J. B., Benjamin E. J., Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in framingham offspring participants without clinical evidence of cardiovascular disease American Journal of Cardiology 2008 101 1 82 88
6. Lteif A. A., Han K., Mather K. J., Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks Circulation 2005 112 1 32 38 (Pubitemid 40962566)
7. Lind L., Arterial compliance and endothelium-dependent vasodilation are independently related to coronary risk in the elderly: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) study Clinical Physiology and Functional Imaging 2008 28 6 373 377
8. Suzuki T., Hirata K., Elkind M. S. V., Jin Z., Rundek T., Miyake Y., Boden-Albala B., Di Tullio M. R., Sacco R., Homma S., Metabolic syndrome, endothelial dysfunction, and risk of cardiovascular events: the Northern Manhattan Study (NOMAS) American Heart Journal 2008 156 2 405 410
9. Hirschi K. K., Ingram D. A., Yoder M. C., Assessing identity, phenotype, and fate of endothelial progenitor cells Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 9 1584 1595
10. Timmermans F., Plum J., Yder M. C., Ingram D. A., Vandekerckhove B., Case J., Endothelial progenitor cells: identity defined? Journal of Cellular and Molecular Medicine 2009 13 1 87 102
11. Fadini G. P., Baesso I., Albiero M., Sartore S., Agostini C., Avogaro A., Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau Atherosclerosis 2008 197 2 496 503
12. Kunz G. A., Liang G., Cuculoski F., Gregg D., Vata K. C., Shaw L. K., Goldschmidt-Clermont P. J., Dong C., Taylor D. A., Peterson E. D., Circulating endothelial progenitor cells predict coronary artery disease severity American Heart Journal 2006 152 1 190 195 (Pubitemid 43974737)
13. Keymel S., Kalka C., Rassaf T., Yeghiazarians Y., Kelm M., Heiss C., Impaired endothelial progenitor cell function predicts age-dependent carotid intimal thickening Basic Research in Cardiology 2008 103 6 582 586
14. Schmidt-Lucke C., Rssig L., Fichtlscherer S., Vasa M., Britten M., Kmper U., Dimmeler S., Zeiher A. M., Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair Circulation 2005 111 22 2981 2987 (Pubitemid 40814192)
15. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Bhm M., Nickenig G., Circulating endothelial progenitor cells and cardiovascular outcomes The New England Journal of Medicine 2005 353 10 999 1007 (Pubitemid 41262334)
16. Hill J. M., Zalos G., Halcox J. P. J., Schenke W. H., Waclawiw M. A., Quyyumi A. A., Finkel T., Circulating endothelial progenitor cells, vascular function, and cardiovascular risk The New England Journal of Medicine 2003 348 7 593 600 (Pubitemid 36204953)
17. Fadini G. P., De Kreutzenberg S. V., Coracina A., Baesso I., Agostini C., Tiengo A., Avogaro A., Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk European Heart Journal 2006 27 18 2247 2255 (Pubitemid 44412842)
18. Fadini G. P., Coracina A., Baesso I., Agostini C., Tiengo A., Avogaro A., De Kreutzenberg S. V., Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population Stroke 2006 37 9 2277 2282 (Pubitemid 44337169)
19. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., Zeiher A. M., Dimmeler S., Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease Circulation Research 2001 89 1 E1 7
20. Fadini G. P., Agostini C., Boscaro E., Avogaro A., Mechanisms and significance of progenitor cell reduction in the metabolic syndrome Metabolic Syndrome and Related Disorders 2009 7 1 5 10
21. Jialal I., Endothelial progenitor cell status in metabolic syndrome Metabolic Syndrome and Related Disorders 2010 8 3 193 195
22. Westerweel P. E., Visseren F. L., Hajer G. R., Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy European Heart Journal 2008 29 22 2808 2817
23. Jialal I., Devaraj S., Singh U., Huet B. A., Decreased number and impaired functionality of endothelial progenitor cells in subjects with metabolic syndrome: implications for increased cardiovascular risk Atherosclerosis 2010 211 1 297 302
24. Werner N., Nickenig G., Clinical and therapeutical implications of EPC biology in atherosclerosis Journal of Cellular and Molecular Medicine 2006 10 2 318 332 (Pubitemid 44870182)
25. Satoh M., Ishikawa Y., Takahashi Y., Itoh T., Minami Y., Nakamura M., Association between oxidative DNA damage and telomere shortening in circulating endothelial progenitor cells obtained from metabolic syndrome patients with coronary artery disease Atherosclerosis 2008 198 2 347 353 (Pubitemid 351707385)
26. Vignera S. L., Condorelli R., Vicari E., d'Agata R., Calogero A. E., Circulating EPCs and EMPS in patients with arterial erectile dysfunction with metabolic syndrome. Journal of Andrology. In press
27. Fadini G. P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., Menegolo M., Vigili De Kreutzenberg S., Tiengo A., Agostini C., Avogaro A., Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus Journal of the American College of Cardiology 2005 45 9 1449 1457 (Pubitemid 40615617)
28. Egan C. G., Lavery R., Caporali F., Fondelli C., Laghi-Pasini F., Dotta F., Sorrentino V., Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes Diabetologia 2008 51 7 1296 1305
29. Fadini G. P., An underlying principle for the study of circulating progenitor cells in diabetes and its complications Diabetologia 2008 51 7 1091 1094
30. Steinmetz M., Nickenig G., Werner N., Endothelial-regenerating cells: an expanding universe Hypertension 2010 55 3 593 599
31. Jialal I., Fadini G. P., Pollock K., Devaraj S., Circulating levels of endothelial progenitor cell mobilizing factors in the metabolic syndrome American Journal of Cardiology 2010 106 11 1606 1608
32. Waltenberger J., VEGF resistance as a molecular basis to explain the angiogenesis paradox in diabetes mellitus Biochemical Society Transactions 2009 37 6 1167 1170
33. Gonalves F. M., Jacob-Ferreira A. L. B., Gomes V. A., Casella-Filho A., Chagas A. C. P., Marcaccini A. M., Gerlach R. F., Tanus-Santos J. E., Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome Clinica Chimica Acta 2009 403 1-2 173 177
34. Huang P. H., Chen Y. H., Wang C. H., Chen J. S., Tsai H. Y., Lin F. Y., Lo W. Y., Wu T. C., Sata M., Chen J. W., Lin S. J., Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor Cells Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1179 1184